Precision Engineered Medical Components

Delivering solutions for over 30 years

Caragh Precision in Action

Caragh Precision in Action

European Regional Development Fund

    Management Development in Caragh Precision

Project Description: Management Development initiatives in Caragh Precision are co-funded by the European Regional Development Fund and Enterprise Ireland under the Border, Midland and Western Regional Operational Programme 2014-2020.

Aims: The aim of this project is to develop a Company-wide competence in the area of PPAP (Production Part Approval Process) in anticipation of future trends in the global medical device manufacturing industry.

Results: An experienced management resource with suitable expertise was identified and appointed with a brief to develop the necessary competencies throughout the business

    Capital Investment in Caragh Precision

Capital Investment Initiatives in this Company are co-funded by the European Regional Development Fund (ERDF) and Enterprise Ireland under the Border, Midland and Western Regional Operational Programme 2014-2020.

The aim of this investment is to purchase physical assets. Increased productivity and competitiveness was achieved as a result of this investment.

    R&D in Caragh Precision

Project Description: R&D initiatives in Caragh Precision are co-funded by the European Regional Development Fund and Enterprise Ireland under the Border, Midland and Western Regional Operational Programme 2014-2020.

Aims: The aims are (i) to develop an advanced manufacturing process in the area of orthopaedic medicine and (ii) to develop manufacturing processes for miniaturised components in the area of minimally invasive cardiovascular medicine. A further aim is to increase overall R&D activity which will drive company development.

Results: The orthopaedic products manufacturing process has been developed to a high level of efficiency and has resulted in increased business from one multinational producer and serious interest from another. Further work is in hand to develop material finishing to a very high standard. In the cardiovascular area, processes have been developed to manufacture more than thirty complex components for four multinational customers and comparable levels of development are ongoing.

 

Logo EUSIFP Logo ERDF Enterprise Ireland Logo